Related references
Note: Only part of the references are listed.Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan
Shohei Nakamura et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis
Hanqing Liu et al.
CANCER MEDICINE (2021)
COVID-19 mortality in cancer patients: a report from a tertiary cancer centre in India
Anurag Mehta et al.
PEERJ (2021)
Lung cancer patients with COVID-19 in Spain: GRAVID study
Mariano Provencio et al.
LUNG CANCER (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy)
Elisa Maria Stroppa et al.
FUTURE ONCOLOGY (2020)
Clinical characteristics and outcomes of cancer patients with COVID-19
Fan Yang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Mengyuan Dai et al.
CANCER DISCOVERY (2020)
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Vikas Mehta et al.
CANCER DISCOVERY (2020)
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Lennard Y. W. Lee et al.
LANCET (2020)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer et al.
LANCET (2020)
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
Kunyu Yang et al.
LANCET ONCOLOGY (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
G. Curigliano et al.
ANNALS OF ONCOLOGY (2020)
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
Souad Assaad et al.
EUROPEAN JOURNAL OF CANCER (2020)
SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death
Ramon Yarza et al.
EUROPEAN JOURNAL OF CANCER (2020)
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies
Jose Maria Sanchez-Pina et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy
Thomas A. Fox et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China
Hongyan Zhang et al.
CANCER (2020)
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment
Ernesto Rossi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
Bo Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
Marina Chiara Garassino et al.
LANCET ONCOLOGY (2020)
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
Astrid Lievre et al.
EUROPEAN JOURNAL OF CANCER (2020)
A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19
Emre Yekeduz et al.
EUROPEAN JOURNAL OF CANCER (2020)
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
David J. Pinato et al.
CANCER DISCOVERY (2020)
Chemotherapy and COVID-19 Outcomes in Patients With Cancer
Justin Jee et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
Julio Garcia-Suarez et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Association of immune checkpoint inhibitors with respiratory infections: A review
Ryosuke Hamashima et al.
CANCER TREATMENT REVIEWS (2020)
COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis
Aakash Desai et al.
JCO GLOBAL ONCOLOGY (2020)
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy
Shigeru Kusumoto et al.
BLOOD (2019)
PD-1 and PD-L1 in locoregionally advanced nasopharyngeal carcinoma: Substudy of a randomized phase III trial
Caineng Cao et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung Cancer
Lorena Ostios-Garcia et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Robert L. Ferris et al.
ORAL ONCOLOGY (2018)
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
Edward S. Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Share Paper
